Patients with Graves’ orbitopathy, diabetes mellitus, and dysthyroid optic neuropathy (n=5)
| Patient (age in years) | Sex | DM | Retinopathy | VA before DON treatment | DON treatment | VA after treatment | Comment |
|---|---|---|---|---|---|---|---|
| 1 (60) | F | IDDM | — | 0.6 0.6 | steroids orally two wall orbital decompression | 0.6 0.6 | |
| 2 (66) | F | NIDDM | — | 0.6 0.6 | two wall orbital decompression steroids iv | 0.5 0.8 | |
| 3 (65) | F | IDDM | — | 0.1 0.4 | three wall orbital decompression | 0.5 0.4 | |
| 4 (60) | F | IDDM | background retinopathy, panretinal photocoagulation scars | 0.016 0.25 | steroids iv two wall orbital decompression | 0.25 0.25 | |
| 5 (65) | M | NIDDM | — | 0.5 0.6 | steroids iv | 0.6 1.0 | also myasthenia gravis |
DM=diabetes mellitus; IDDM=insulin dependent diabetes mellitus; NIDDM=non-insulin dependent diabetes mellitus; VA=visual acuity; DON=dysthyroid optic neuropathy.